RecallDepth
Class II Terminated

Irbesartan Tablets USP, 75 mg a) 30 count (NDC 68180-410-06) and b) 90 count (NDC 68180-410-09) bottles, Rx only

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
October 12, 2021
Posted
November 10, 2021
Recall Number
D-0086-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
51,144 bottles
Firm Location
Baltimore, MD, United States

Reason for Recall

CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Distribution

Product was distributed to major distributors who may have further distributed the product nationwide.

Lot / Code Info

a) Lot# H000843, exp. date 28/02/2023 H805727, exp. date 30/11/2021 H901579, exp. date 31/03/2022 b) Lot# H000844, exp. date 28/02/2023 H000964, exp. date 31/03/2023 H804311, exp. date 31/08/2021 H805267, exp. date 30/11/2021 H805268, exp. date 30/11/2021 H805269, exp. date 30/11/2021 H805725, exp. date 30/11/2021 H805726, exp. date 30/11/2021 H901497, exp. date 31/01/2022 H901577, exp. date 31/03/2022 H901578, exp. date 31/03/2022 H902258, exp. date 31/05/2022

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls